Genmab — September 2019
-
https://www.bebpa.org/2019-eu-bioassay-abstracts/ Lidt nede i
omtales et indlæg om Gen1029 -
Genmab Announces U.S. FDA Approval of DARZALEX
(daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone for Frontline Multiple Myeloma
September 26, 2019 at 5:43 PM CEST
Company AnnouncementDARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, thalidomide (an immunomodulatory agent) and dexamethasone as treatment for patients newly diagnosed with multiple myeloma who are eligible for autologous stem cell transplant
Approval based on Phase III CASSIOPEI -
-
God nyhed...igen...
-
well , then let me repeat this also
Prof. Philippe Moreau: "I think that when we are going to use quadruplet combination including CD38 antibodies plus SCT, we are going to #cure some young patients" in this interview on #daratumumab + VTdhttps://www.targetedonc.com/news/daratumumab-improves-responses-pfs-in-newly-diagnosed-transplanteligible-myeloma -
-
Peter og Legolas...Jeg deler ikke en "nyhed" 19,46. Den delte jeg et utal af steder da den kom fra Genmab. Det jeg deler er som vanligt finansmediernes version af nyheden. Det være sig fra Børsen, Medwatch eller andre medier.
-
Af og til er der en ny vinkel på. Det er dog sjældent.
-
AL Amyloidosis for the Cardiologist and Oncologist https://cardiooncology.onlinejacc.org/content/1/1/117
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind